Wells Fargo’s CARGO Therapeutics CRGX Stock Holding History

Wells Fargo’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-22,766	Closed	-$93.8K	–	7138
2025 Q2	$93.8K	Buy	22,766 +2,577	+13%	+$11K	﹤0.01%	5231
2025 Q1	$82.2K	Buy	20,189 +449	+2%	+$3.01K	﹤0.01%	5204
2024 Q4	$285K	Buy	19,740 +4,497	+30%	+$81.6K	﹤0.01%	4567
2024 Q3	$281K	Buy	15,243 +6,850	+82%	+$123K	﹤0.01%	4354
2024 Q2	$138K	Buy	8,393 +1,337	+19%	+$25.4K	﹤0.01%	4754
2024 Q1	$157K	Buy	7,056 +6,913	+4,834%	+$164K	﹤0.01%	4618
2023 Q4	$3.31K	Buy	+143	New	+$2.42K	﹤0.01%	6021

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wells Fargo's CRGX Position: Q3 2025 in Review

Wells Fargo sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 22,766 shares — an estimated $93.8K sold.

Wells Fargo first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $285K in Q4 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Wells Fargo reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Wells Fargo sold 22,766 CARGO Therapeutics shares in Q3 2025, an estimated $93.8K.
Wells Fargo first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
Wells Fargo's CARGO Therapeutics position peaked at $285K in Q4 2024.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.